An enantiomer-selective amidase active on several 2-aryl and 2-aryloxy propionamides was identified and purified from Brevibacterium sp. strain R312. Oligonucleotide probes were designed from limited peptide sequence information and were used to clone the corresponding gene, named amdA. Highly significant homologies were found at the amino acid level between the deduced sequence of the enantiomer-selective amidase and the sequences of known amidases such as indoleacetamide hydrolases from Pseudomonas syringae and Agrobacterium tumefaciens and acetamidase from Aspergillus nidulans. Moreover, amdA is found in the same orientation and only 73 bp upstream from the gene coding for nitrile hydratase, strongly suggesting that both genes are part of the same operon. Our results also showed that Rhodococcus sp. strain N-774 and Brevibacterium sp. strain R312 are probably identical, or at least very similar, microorganisms. The characterized amidase is an apparent homodimer of Mr 2 x 54,671 which exhibited under our conditions a specific activity of about 13 to 17 imol of 2-(4-hydroxyphenoxy)propionic R acid formed per min per mg of enzyme from the racemic amide. Large amounts of an active recombinant enzyme could be produced in Escherichia coli at 30TC under the control of an E. coli promoter and ribosome-binding site.
Nitriles are extensively used in organic synthesis by the chemical industry as precursors to produce compounds such as amides and organic acids. However, the chemical conversion of nitrites presents several disadvantages, such as the need for strongly acidic or basic conditions, a high energy consumption, or the formation of unwanted by-products. More recently developed biochemical procedures in which microorganisms are used as catalysts look promising because temperature and pH conditions are less severe and because very pure products can be formed (23) . In addition, bioconversions can be stereospecific and can lead to the production of a single enantiomer, which might be a crucial aspect in the manufacturing of active new drugs (5) . However, the use of very efficient microbial strains is necessary to develop a biochemical process at the industrial scale. For instance, an efficient process for the production of acrylamide from acrylonitrile using resting cells of Pseudomonas chlororaphis B23 has recently been developed (21) .
Many microorganisms can use nitrites as a sole carbon and/or nitrogen source. Among them, the potential use of Brevibacterium sp. strain R312 was recognized several years ago by Arnaud and colleagues (1) . This gram-positive coryneform strain was shown to contain two types of enzyme activities for the hydrolysis of nitrites: a nitrile hydratase that hydrates nitrites into amides (6) and probably several amidases which transform amides into the corresponding organic acids (13) . The bioconversion of water-soluble amides in a continuous immobilized cell reactor was also demonstrated (3) . Such experiments led to the view that this type of corynebacteria may be viewed as "bags," preventing ENANTIOMER-SELECTIVE AMIDASE FROM BREVIBACTERIUM SP. (18) . Brevibacterium genomic DNA was prepared as described previously (9) . The Sequenase Version 2-0 (United States Biochemical Corp.) was used for DNA sequencing with [kx-355] dATP (Amersham Corp.). 7-Deaza-dGTP was substituted for dGTP to reduce compression caused by the high G+C percentage. Polymerase chain reaction experiments were performed using the Taq polymerase from Cetus and the Perkin-Elmer Cetus DNA thermal cycler as recommended by the manufacturer. Proteins were fractionated by PAGE under denaturing conditions (18) .
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Enzyme assay. The enzyme activity on HPPAmide (20 mM) was monitored during stirring at 25°C in 4 ml of 50 mM sodium phosphate buffer (pH 7.0). The reaction was stopped by the addition of a 90:10 (%) (vol/vol) mixture of acetonitrile and 1 N HC1, respectively. After homogenization and centrifugation, the supernatant was applied to an HPLC reverse-phase column (Hibar-Merck RP-18; 5 pLm). The elution at 1 ml/min by an 85:15 (vol/vol) mixture of phosphoric acid (0.05 M) and acetonitrile, respectively, was monitored by the optical density at 280 nm, and the respective concentrations of HPPAmide and HPPAcid in the analyzed sample were measured from the peak positions and areas of standards.
Enantiomer selectivity assays. The enantiomer excess (ee), defined as the ratio [(R -S)I(R + S)] x 100 (%), where R and S are, respectively, the concentrations of the R(+) and S(-) HPPAcid enantiomers, was deduced from HPLC on a chiral column (Resolvosil BSA 7; Macherey-Nagel) with the following elution buffer: sodium phosphate (pH 6.8)-10 mM isopropanol (95/5, vol/vol). Under these conditions, the retention times of the R(+) and S(-) forms were 7.2 and 13 min, respectively.
Purification of enantiomer-selective amidase activity. All procedures were done at 4°C.
(i) Step Cells were broken by ultrasonic treatment, and cell debris was separated by centrifugation at 20,000 x g for 30 min. A 25-ml portion of a 10% solution of streptomycin sulfate was then slowly added under gentle agitation to 310 ml of the supernatant. After 45 min, the solution was clarified as described above and the supernatant was submitted to the following steps.
(ii)
Step 2. Ammonium sulfate fractionation. The protein fraction precipitating between 30.8 and 56.6% saturation with ammonium sulfate was collected by centrifugation and dissolved in 35 ml of buffer A. This solution was further desalted by extensive dialysis against the same buffer.
(iii)
Step 3. Phenyl-Sepharose CL-4B chromatography. The protein fraction was brought to 20% saturation with ammonium sulfate, clarified by centrifugation, and applied onto a column of phenyl-Sepharose CL-4B (Pharmacia) equilibrated with buffer A at 20% saturation with ammonium sulfate. Protein fractions containing the enzyme activity were eluted with the same buffer, pooled, and concentrated by ultrafiltration with an Amicon Diaflo PM10 cell to a volume of 18 ml.
(iv) Steps 4 and 5. Gel filtration. Glycerol (10%) was added to the concentrated protein fraction, and the solution was loaded on an Ultrogel AcA 44 (IBF-biotechnics, Villeneuvela-Gareivne, France) column which had been equilibrated in 50 mM Tris hydrochloride (pH 7.0-100 mM NaCl. Protein fractions containing the highest specific activity (about 32% of the total activity loaded on the column) were collected, concentrated, and submitted to an additional filtration step on the same gel. Once again, fractions (about 30% of applied proteins) exhibiting the highest specific activity were analyzed by SDS-PAGE and pooled. The enantiomer selectivity of the purified protein obtained by this procedure was also checked (ee > 95%).
Protein sequencing. About 3 nmol of the purified amidase preparation was reduced and carboxymethylated. Oligonucleotide probes. Oligodeoxynucleotides were synthesized with a Biosearch 8600 automatic DNA synthesizer and purified by PAGE under denaturing conditions as previously described (8) . Probe A was derived from part of the internal peptide sequence (IDGALGSYDV) on the noncoding strand as the following degenerated 29-mer: 5'-ACGT CGTAGGAGCC(G,C)AG(G,C,T)GCGCCGTCGAT-3'. An exact probe from the N-terminal sequence was designed by polymerase chain reaction as follows. Briefly, two highly degenerated oligonucleotides corresponding to nearly all coding possibilities of the first and last five amino acids of the N-terminal sequence and flanked with a restriction site were synthesized: 5'-CGGAATTCGCNACNAT (T,C,A)GNCC NGA-3' (direct orientation, EcoRI site) and 5'-CCAAGC1[ GCNGT(T,C)TT(A,G)TCNA(G,A) NGT-3' (reverse orientation, HindIII site), where N corresponds to an equimolar mixture of the four bases. These oligonucleotides were used to prime 30 cycles of enzymatic amplification by the Taq polymerase on the total genomic DNA of Brevibacterium sp. strain R312 as described previously (10 Cloning of the enantiomer-selective amidase. The N-terminal peptide sequence (27 residues) and the sequence of an internal fragment (21 residues) of the major polypeptide species in the purified preparation were determined as described in Materials and Methods. From these peptide sequences, two different oligonucleotide probes were designed. Probe A is a six-fold-degenerated 29-mer derived from the internal fragment, taking into account the codon usage in the tryptophan operon of Brevibacterium lactofermentum (19) . For the other probe, the polymerase chain reaction procedure described by Girgis et al. (10) was performed to generate an exact 40-mer nucleotide probe (probe B) from the N-terminal sequence. These synthetic DNAs were then 32p labeled and used as hybridization probes. Southern hybridization with these probes against several digestions of the Brevibacterium sp. chromosomal DNA revealed that, at least for several restriction enzymes, probes A and B hybridized with the same fragment (data not shown). In particular, both probes hybridized with a single 5.4-kb PstI fragment. The PstI-digested chromosomal fragments of 4.8 to 6.3 kb were purified by agarose gel electrophoresis, ligated with PstI-digested pUC19 plasmid, and introduced into E. coli DH5a. About 500 ampicillin-resistant white transformants on X-gal medium obtained in this way were individually screened by colony hybridization with probe B. Two colonies showing a strong positive hybridization to both probes A and B were found. Restriction analysis of corresponding plasmid DNAs (pXL1650 and pXL1651) indicated that they had inserted the same 5.4-kb PstI fragment in either of the two possible orientations. A restriction map of this fragment is shown in Fig. 1 . Supercoil DNA sequencing with both probes as primers and additional Southern analysis of the plasmids confirmed that the correct chromosomal fragment had been cloned, indicated that the two previously determined peptide sequences were next to each other in the protein, and showed that the studied gene was contained on a 2.3-kb BamHI-PstI fragment (Fig. 1) .
Nucleotide sequence of enantiomer-selective amidase gene and structural evidence for coupling with the gene coding for nitrile hydratase. The nucleotide sequence of the BamHIPstI fragment was determined as detailed in Fig. 1 . The 2,447-bp-long sequence is shown in Fig. 2 (Fig. 2) , which may reflect either a sequence error or a minor allelic variation. The identity at the DNA level between the sequences of such long fragments from the two strains strongly argues in favor of Rhodococcus sp. strain N-774 (28) and Brevibacterium sp. strain R312 (1) being identical, or at least very closely related, microorganisms. An additional proof was provided by the cloning of the 3' overlapping 3.9-kbp HindIII-SphI genomic fragment from Brevibacterium sp. strain R312 (data not shown). The restriction map of this fragment was found to be in total agreement with the structure of the corresponding Rhodococcus sp. strain N-774 fragment (11) . It was also verified that the structural genes for the two subunits of nitrile hydratase were identical for both microorganisms (data not shown). It can thus be concluded that the genes coding for the enantiomer-selective amidase and nitrile hydratase, two enzymes catalyzing successive reactions from nitriles to the corresponding acids, are closely linked on the bacterial genome.
Sequence homology with known amidases. A systematic search of the NRBF and GENPRO protein data bases for good local homologies with the amidase sequence (15) gave known amidases as the best matches. Highly significant homologies were found with indoleacetamide hydrolase from Pseudamonas syringae (29) and Agrobacterium tumefaciens (24) , also known as the protein encoded by the tms2 locus of plasmid Ti. These amidases are used by their phytopathogenic hosts to produce indoleacetic acid from indoleacetamide, indoleacetic acid being recognized as the principal auxin of higher plants. As shown in Fig. 3A by dot matrix analysis, the homology is clustered in the N-terminal half of the proteins (a40% match with the P. syringae enzyme), in particular between residues 150 and 220 of the strain R312 amidase. Two stretches of 10 and 12 consecutive identical residues between the P. syringae and the R312 enzymes are found between residues 168 and 204 of the R312 amidase. This region is also highly conserved in both the indoleacetamide hydrolase of A. tumefaciens and the acetamidase of Aspergillus nidulans (7) (Fig. 3B) , strongly suggesting that it is part of the active site of these amidases. Finally, we noted that the homology between the enantiomer-selective amidase of Brevibacterium sp. strain R312 and the indoleacetamide hydrolase of P. syringae is of the same order as the homology between the indoleacetamide hydrolases of P. syringae and A. tumefaciens.
Expression of Brevibacterium sp. strain R312 amidase activity in E. coli. The expression of amidase was first analyzed in the recombinant E. coli DH5ot strain containing either of the original clones pXL1650 and pXL1651. These plasmids carry the same 5.4-kbp chromosomal PstI fragment (Fig. 1) cloned in either orientation in the polylinker of plasmid pUC19. Even under conditions known to derepress the lac promoter, we could not detect by Coomassie blue staining any expression of the cloned gene (data not shown). In another experiment, the 2.26-kbp BamHI-PstI fragment containing the complete amidase gene and the 58 bp upstream of the ATG codon was subcloned into a ptp expression vector (8, 16a) to give pXL1724. Once again, no detectable synthesis of the presumed amidase protein could be evidenced by Coomassie blue staining, whatever the conditions (data not shown). The intrinsic expression capacity of these vectors could not be questioned since a protein of the expected size was specifically synthesized in an in vitro coupled transcription-translation assay (Amersham) when pXL1650, pXL1724, and, to a much weaker extent, pXL1651 were used as templates (data not shown). All these results strongly suggested that neither the amidase promoter, if present in the 3 kbp 5' to the gene, nor the translation initiation signals of the gene were efficient in E. coli. Two other constructions were then made in which the structural gene for amidase was linked to both a strong E. coli promoter, such as the Ptrp or X PR promoter, and an efficient RBS, such as that derived from the X cII gene (8) . Expression of amidase from these vectors, pXL1751 (Ptrp) and pXL1752 (PR), was studied in E. coli B and E103S, respectively, two host strains known to give a high level of expression of heterologous proteins. Results shown in Fig. 4 demonstrate the specific high-level expression of an Mr-55,000 protein, corresponding to at least 20% of total protein and comigrating with the main.protein species of the purified amidase preparation from Brevibacterium sp. strain R312 (lanes b and c) . Subsequent analysis revealed that in fact only a minor proportion (<10%) of this protein was expressed as a soluble enzyme (Fig. 4, lanes g and i or n and p) when the recombinant strain was cultivated at 37 or 42°C, indicating that it was mainly produced as an aggregated, denatured protein as already observed for nitrile hydratase (11) . However, when E. coli B(pXL1751) was grown at 30°C, similar amounts of the enzyme were synthesized but mainly (-- without tryptophan), recombinant E. coli strains with up to threefold-higher specific activities than the original Brevibacterium sp. strain R312 were obtained. DISCUSSION This is the first report of the cloning and analysis of an amidase gene from a coryneform species. The R312 strain was isolated by Arnaud and co-workers (1) coli. Coomassie blue staining of SDS-polyacrylamide gels. An 8.5% gel and a 12.5% gel were used for lanes a to e and f to q, respectively. The positions of amidase (55 kDa) and interleukin-1, (17 kDa) are indicated by the arrowheads. Lanes: a and k, molecular size standards; b and d, purified amidase from R312; c and e, total cell extracts of E103S(pXL1752) after promoter induction at 42°C and incubation at 30°C, respectively; f, h, and j, soluble proteins, total cell extract, and insoluble proteins, respectively, of control E103S(pXL1029) expressing recombinant soluble interleukin-11; g and i, soluble and insoluble proteins, respectively, E103S(pXL1752) expressing amidase; m, o, and q, soluble proteins, total cell extract, and insoluble proteins, respectively, of control E. coli B(pXL906) expressing interleukin-13 under the control of the trp promoter; l, n, and p, same extracts as in lanes m, o, and q, respectively, of the isogenic strain E. coli B(pXL1751) expressing amidase. a wild-type amidase activity (6) . Nitrile hydratase from Brevibacterium sp. strain R312, characterized by a wide substrate spectrum (6), has been purified to homogeneity and is composed of two types of subunits of apparent Mr near 27,000 (22) . The enzyme biosynthesis is not influenced by aE. coli B and E. coli K-12 E103S were used as hosts for expression from the trp (pX1751 and pXL906) and A PR (pXL1752 and pXL1029) promoters, respectively. amdA is expressed from pXL1751 and pXL1752, whereas interleukin-ilp is expressed from pXL906 and pXL1029 (14 (27) . On the other hand, it has been demonstrated that Brevibacterium sp. strain R312 harbors, as other microorganisms, several different types of amidase activities. For instance, an acylamide amidohydrolase (EC 3.5.1.4) with a wide activity spectrum (wide-spectrum amidase) has been characterized (17) . The purified enzyme is apparently a tetramer of four identical subunits (Mr 43,000), is able to hydrolyze a large number of amides into their corresponding organic acids, and also possesses an acyl transferase activity (26) . In a mutant strain, called A4, in which this enzyme is inactivated, another amidase activity able to hydrolyze a large number of a-amino amides has also been identified. An interesting property of this second candidate enzyme, name a-aminoamidase, is its stereospecificity. Contrary to the wide-spectrum amidase, this enzyme is able to produce only L a-amino acids from a-amino amides (16) .
We described in the present work the preliminary characterization and the cloning of a stereospecific amidase which was identified by its ability to hydrolyze racemic 2-aryl or 2-aryloxy propionamides (R312 amidase in this discussion). It is clear from the structures of the purified proteins that this enzyme is different from the wide-spectrum amidase. In addition, we recently performed N-terminal sequencing analysis of the purified wide-spectrum amidase (provided by A. Arnaud, Montpellier, France) and confirmed that the two proteins are indeed different. However, we still cannot exclude that the R312 amidase described here may be identical to the previously identified a-aminoamidase, although a preliminary study of the latter seemed to indicate a very different structure (16 We found important homologies between the R312 amidase and both the A. nidulans acetamidase and the indoleacetamide hydrolases of two different plant pathogens. The significance of these homologies in terms of substrate specificity is not clear. For instance, we found a similar, or even higher, homology between R312 amidase and the P. syringae indoleacetamide hydrolase (32.1%) than between both indoleacetamide hydrolase enzymes from P. syringae and A. tumefaciens (26.4%) (29) , although the latter ones are supposed to carry the same enzymatic functions. However, the very high conservation of nearly 40 residues around position 190 in all these amidases (between 57 and 75% identity) strongly suggests that this portion of the protein constitutes the active catalytic site responsible for the hydrolysis of the amide bond.
Another important conclusion from this work is the colocalization of the amdA gene coding for the stereospecific amidase with the gene for nitrile hydratase. The identification of the latter gene is based on its total identity at the nucleotide level with the corresponding gene of Rhodococcus sp. strain N-774. In fact, it was already known that enzymes from both microorganisms had similar structures (11, 22) , and we recently found (data not shown) that the N-terminal peptide sequences of the two subunits of the purified Brevibacterium enzyme (kindly provided by A. Arnaud, Montpellier) were identical to those reported for the enzyme from Rhodococcus sp. (the sequenced N terminus of the a subunit is indicated in Fig. 2 ). We also take the identity at the nucleotide level of the common sequenced fragment from Brevibacterium sp. strain R312 and Rhodococcus sp. strain N-774 (one nucleotide difference in more than 1.55 kb) as a strong indication that both microorganisms should be at least very closely related, if not identical. It seems plausible from the above observations that nitrile hydratase can be expressed from a polycistronic mRNA initiated upstream from amdA since no sequence reminiscent of a transcription terminator can be found in the intercistronic region between the two genes; moreover, it has been shown, at least in E. coli (11) , that nitrile hydratase can be expressed from a promoter inserted at the SphI site, located in amdA. We interpret this gene arrangement as an indication that the bacterial cell needs to coregulate, at least under some conditions, the gene expression of both enzymes.
The lack of significant expression of the R312 amidase in E. coli either from the PstI fragment (native promoter and RBS) or from the BamHI-PstI fragment (native RBS and E. coli promoter) is difficult to interpret in the context of previous results suggesting that the transcriptional and translational machineries could recognize similar signals in E. coli and coryneform bacteria (at least Corynebacterium glutamicum). Work is in progress to map the promoter and to check whether R312 amidase can be readily expressed from native signals in prototype coryneform bacteria such as C. glutamicum or B. lactofermentum. It is also interesting to observe that, when expressed from E. coli signals, the solubility of the overexpressed protein is very dependent on the growth temperature between 30 and 37°C, although similar expression levels are obtained. That amidase cannot properly refold and reach its active three-dimensional conformation in vivo at 37°C appears to be the most obvious explanation. Moreover, specific activities measured on whole cells are well correlated to the observed solubilities. These results suggest not only that the production of an active Brevibacterium amidase can be obtained in E. coli but also that whole recombinant E. coli cells can indeed be used in the bioconversion of amides.
